| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: VUMERITY (diroximel fumarate)_ | |
| ***************************************************** | |
| #Post#: 2518-------------------------------------------------- | |
| (AAN) Biogen says new MS drug Vumerity (diroximel fumarate) unde | |
| r FDA review | |
| By: agate Date: May 15, 2019, 8:14 pm | |
| --------------------------------------------------------- | |
| Neurofilament light chains received quite a bit of attention at | |
| the annual AAN conference for 2019 (Philadelphia, May 4-10). | |
| They're mentioned in this article from Multiple Sclerosis News | |
| Today (May 15, 2019) entitled "Biogen Offers Update on | |
| Development Plans for MS Therapies." The Biogen spokesperson is | |
| announcing another new MS drug, Vumerity, which is up for FDA | |
| review: | |
| http://bit.ly/2vZW9t9 | |
| ***************************************************** |